Atorvastatin increases intestinal cholesterol absorption in dogs

被引：5
作者：
Briand, Francois
Serisier, Samuel
Krempf, Michel
Siliart, Brigitte
Magot, Thierry
Ouguerram, Khadija
Nguyen, Patrick [1 ]
机构：
[1] Human Nutr Res Ctr, Nantes, France
[2] Natl Vet Sch Nantes, Endocrinol & Nutr Unit, Nantes, France
[3] Univ Hosp, INSERM, U539, Nantes, France
来源：
JOURNAL OF NUTRITION | 2006年 / 136卷 / 07期
关键词：
atorvastatin; cholesterol plasma levels; sterol absorption;
D O I：
10.1093/jn/136.7.2034S
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
引用
收藏
页码：2034S / 2036S
页数：3
相关论文
共 50 条
[31]   Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada [J].
Michele Kohli ;
Cheryl Attard ;
Annette Lam ;
Daniel Huse ;
John Cook ;
Chantal Bourgault ;
Evo Alemao ;
Donald Yin ;
Michael Marentette .
PharmacoEconomics, 2006, 24 :815-830
[32]   Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk [J].
Laufs, Ulrich ;
Karmann, Barbara ;
Pittrow, David .
CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (09) :783-790
[33]   HDL-cholesterol and the treatment of coronary heart disease: Contrasting effects of atorvastatin and simvastatin [J].
Mikhailidis, DP ;
Wierzbicki, AS .
CURRENT MEDICAL RESEARCH AND OPINION, 2000, 16 (02) :139-146
[34]   Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk [J].
Ulrich Laufs ;
Barbara Karmann ;
David Pittrow .
Clinical Research in Cardiology, 2016, 105 :783-790
[35]   Relationship of High-Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin [J].
Ong, Kwok Leung ;
Waters, David D. ;
Fayyad, Rana ;
Vogt, Liffert ;
Melamed, Shari ;
DeMicco, David A. ;
Rye, Kerry-Anne ;
Barter, Philip J. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (02)
[36]   Reduction in coronary heart disease with atorvastatin independent of low-density lipoprotein cholesterol [J].
Takagi, Hisato ;
Umemoto, Takuya .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 149 (02) :267-269
[37]   Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin [J].
Llaverias, G ;
Lacasa, D ;
Viñals, M ;
Vázquez-Carrera, M ;
Sánchez, RM ;
Laguna, JC ;
Alegret, M .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (01) :155-163
[38]   Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs [J].
Briand, F ;
Magot, T ;
Krempf, M ;
Nguyen, P ;
Ouguerram, K .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (04) :224-230
[39]   Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs [J].
Gopaul, V. Sashi ;
Pieterman, Elsbet J. ;
Princen, Hans M. G. ;
Bergenholm, Linnea ;
Lundborg, Eva ;
Cavallin, Anders ;
Johansson, Magnus J. ;
Hawthorne, Glen ;
Bjorkbom, Anders ;
Hammarberg, Maria ;
Li, XueQing ;
Jarke, Annica ;
Bright, Jonathan ;
Svensson, Lena ;
Jansson-Lofmark, Rasmus ;
Abrahamsson, Bertil ;
Agrawal, Rahul ;
Hurt-Camejo, Eva .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 161
[40]   Achievement Rates of Japan Atherosclerosis Society Guidelines 2007 LDL- Cholesterol Goals with Rosuvastatin or Atorvastatin in Patients Who Had Not Achieved Their Goal with Atorvastatin [J].
Shioji, Keisuke ;
Izuhara, Masayasu ;
Mitsuoka, Hirokazu ;
Uegaito, Takashi ;
Matsuda, Mitsuo .
CARDIOVASCULAR THERAPEUTICS, 2014, 32 (03) :97-104
12345